Safety results of the enzalutamide expanded access program in the United States and Canada for patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel Meeting Abstract
| Authors: | Joshua, A. M.; Shore, N. D.; Saad, F.; Chi, K. N.; Olsson, C. A.; Emmenegger, U.; Scholz, M. C.; Berry, W. R.; Mukherjee, S.; Winquist, E.; Haas, N. B.; Hasabou, N.; Dmuchowski, C.; Perabo, F.; Hirmand, M.; Foley, M. A.; Rathkopf, D. E. |
| Abstract Title: | Safety results of the enzalutamide expanded access program in the United States and Canada for patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203443 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.5051 |
| Notes: | Meeting Abstract: 5051 -- Source: Wos |
